Colon Cancer

Posted on Posted in studies2

Current data from a clinical study on patients with colon cancer demonstrated that the Lonicera Tablet Matrix was successful on delivering more than 85% of each tablet bacteria load, in a viable state to a targeted area in the gut. The probiotic remedy used for this trial,

was the “ProBion Clinica” product by Wasa Medical.  The ProBion probiotic remedy  changed the bacterial profile in the colon of the subjects to a profile similar to healthy individuals as well as it changed the methylation pattern in the tumour cells, which could result in activation of tumour suppressor genes.